Enable in-process analytics for your capsids
When it comes to viral vector based gene therapies, it is necessary to evaluate the stability and integrity of viral vector capsids. Having the right analytics for your gene therapy helps you bring a safe and effective drug to market. Time is also critical when getting a drug to market. That is why finding a robust technique that produces fast, reliable results is key.
However, current methods can be very time consuming and may not provide the sensitivity required to efficiently determine the quality of the capsids. There is also a lack of reliable and reproducible methods to cost-effectively manufacture these gene therapies.
This is where SCIEX comes in. SCIEX CE and LC-MS solutions provide you with precision analytics that give you the answers you need the first time around, while using small sample amounts, so you can bring a safe, effective drug to market faster.